Abstract
Purpose
The objective of this study is to evaluate the role of Crooke’s changes (CC) in normal the peri-tumoral anterior pituitary gland, in patients with Cushing’s disease (CD) with a histopathological confirmed corticotroph adenoma, and determine if there is any difference in the recurrence and remission rates in CD patients after treatment with Gamma Knife Radiosurgery (GKRS).
Methods
All patients treated with GKRS for CD from 2005 to 2016 at our institution were identified. Patients had a confirmed adrenocorticotropic (ACTH)-secreting adenoma, i.e. corticotroph adenoma, and normal pituitary gland included in the surgical specimen, and specimens were stained with hematoxylin and eosin and also immunostaining for cytokeratin and ACTH. Statistical analyses were performed in a total of 61 patients who met the inclusion criteria. Additionally, we analyzed 20 patients in each group, with and without CC, after they were matched in a propensity score fashion.
Results
Endocrine remission defined as, a normal 24 h urine free cortisol while off suppressive medication, occurred in 48 patients (78.7%), with 76.9% in those with CC and 81.8% in those without CC. There was no statistical significant difference between the two groups in regarding remission (p = 0.312) or recurrence (p = 0.659) in either the unmatched or matched cohorts.
Conclusion
The presence or absence of CC in normal pituitary gland does not appear to confer a lower rate of remission or a higher rate of recurrence after GKRS. Patients with pituitary corticotroph adenomas that present with CC features may be well served by Stereotactic radiosurgery (SRS).
Similar content being viewed by others
References
Crooke A (1935) Change in the basophil cells of the pituitary gland common to conditions which exhibit the syndrome attributed to basophil adenoma. J Pathol Bacteriol 41:339–349
Laqueur GL (1950) Cytological changes in human hypophyses after cortisone and ACTH treatment. Science 112(2911):429–430
Oldfield EH, Vance ML, Louis RG, Pledger CL, Jane JA Jr, Lopes MB (2015) Crooke’s changes in cushing’s syndrome depends on degree of hypercortisolism and individual susceptibility. J Clin Endocrinol Metab 100(8):3165–3171. https://doi.org/10.1210/JC.2015-2493
Kovacs K (1993) The pathology of cushing’s disease. J Steroid Biochem Mol Biol 45(1–3):179–182
Eschbacher JM, Coons SW (2006) Cytokeratin CK20 is a sensitive marker for crooke’s cells and the early cytoskeletal changes associated with hypercortisolism within pituitary corticotrophs. Endocr Pathol 17(4):365–376
Mete O, Lopes MB (2017) Overview of the 2017 WHO classification of pituitary tumors. Endocr Pathol 28(3):228–243. https://doi.org/10.1007/s12022-017-9498-z
Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156(2):203–216. https://doi.org/10.1530/eje.1.02326
Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101(3):613–619. https://doi.org/10.1002/cncr.20412
George DH, Scheithauer BW, Kovacs K, Horvath E, Young WF Jr, Lloyd RV, Meyer FB (2003) Crooke’s cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma. Am J Surg Pathol 27(10):1330–1336
Mohammed S, Kovacs K, Mason W, Smyth H, Cusimano MD (2009) Use of temozolomide in aggressive pituitary tumors: case report. Neurosurgery 64(4):E773-774. https://doi.org/10.1227/01.NEU.0000339115.12803.4E
Takeshita A, Inoshita N, Taguchi M, Okuda C, Fukuhara N, Oyama K, Ohashi K, Sano T, Takeuchi Y, Yamada S (2009) High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing’s disease. Eur J Endocrinol 161(4):553–559. https://doi.org/10.1530/EJE-09-0414
Kovacs GL, Goth M, Rotondo F, Scheithauer BW, Carlsen E, Saadia A, Hubina E, Kovacs L, Szabolcs I, Nagy P, Czirjak S, Hanzely Z, Kovacs K, Horvath E, Korbonits M (2013) ACTH-secreting Crooke cell carcinoma of the pituitary. Eur J Clin Investig 43(1):20–26. https://doi.org/10.1111/eci.12010
Hague K, Post KD, Morgello S (2000) Absence of peritumoral Crooke’s change is associated with recurrence in surgically treated Cushing’s disease. Surg Neurol 53(1):77–81
Sheehan JP, Pouratian N, Steiner L, Laws ER, Vance ML (2011) Gamma knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes. J Neurosurg 114(2):303–309. https://doi.org/10.3171/2010.5.JNS091635
Pollock BE, Nippoldt TB, Stafford SL, Foote RL, Abboud CF (2002) Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas: factors associated with endocrine normalization. J Neurosurg 97(3):525–530. https://doi.org/10.3171/jns.2002.97.3.0525
Jagannathan J, Sheehan JP, Pouratian N, Laws ER, Steiner L, Vance ML (2007) Gamma knife surgery for Cushing’s disease. J Neurosurg 106(6):980–987. https://doi.org/10.3171/jns.2007.106.6.980
Mehta GU, Ding D, Patibandla MR, Kano H, Sisterson N, Su YH, Krsek M, Nabeel AM, El-Shehaby A, Kareem KA, Martinez-Moreno N, Mathieu D, McShane B, Blas K, Kondziolka D, Grills I, Lee JY, Martinez-Alvarez R, Reda WA, Liscak R, Lee CC, Lunsford LD, Vance ML, Sheehan JP (2017) Stereotactic radiosurgery for cushing disease: results of an international, multicenter study. J Clin Endocrinol Metab 102(11):4284–4291. https://doi.org/10.1210/jc.2017-01385
Snell JW, Sheehan J, Stroila M, Steiner L (2006) Assessment of imaging studies used with radiosurgery: a volumetric algorithm and an estimation of its error. Technical note. J Neurosurg 104(1):157–162. https://doi.org/10.3171/jns.2006.104.1.157
Hassan-Smith ZK, Sherlock M, Reulen RC, Arlt W, Ayuk J, Toogood AA, Cooper MS, Johnson AP, Stewart PM (2012) Outcome of cushing’s disease following transsphenoidal surgery in a single center over 20 years. J Clin Endocrinol Metab 97(4):1194–1201. https://doi.org/10.1210/jc.2011-2957
Pouratian N, Prevedello DM, Jagannathan J, Lopes MB, Vance ML, Laws ER Jr (2007) Outcomes and management of patients with Cushing’s disease without pathological confirmation of tumor resection after transsphenoidal surgery. J Clin Endocrinol Metab 92(9):3383–3388. https://doi.org/10.1210/jc.2007-0208
Hammer GD, Tyrrell JB, Lamborn KR, Applebury CB, Hannegan ET, Bell S, Rahl R, Lu A, Wilson CB (2004) Transsphenoidal microsurgery for Cushing’s disease: initial outcome and long-term results. J Clin Endocrinol Metab 89(12):6348–6357. https://doi.org/10.1210/jc.2003-032180
Valassi E, Biller BM, Swearingen B, Pecori Giraldi F, Losa M, Mortini P, Hayden D, Cavagnini F, Klibanski A (2010) Delayed remission after transsphenoidal surgery in patients with Cushing’s disease. J Clin Endocrinol Metab 95(2):601–610. https://doi.org/10.1210/jc.2009-1672
Patil CG, Veeravagu A, Prevedello DM, Katznelson L, Vance ML, Laws ER Jr (2008) Outcomes after repeat transsphenoidal surgery for recurrent Cushing’s disease. Neurosurgery 63(2):266–270. https://doi.org/10.1227/01.NEU.0000313117.35824.9F
Aghi MK, Petit J, Chapman P, Loeffler J, Klibanski A, Biller BM, Swearingen B (2008) Management of recurrent and refractory Cushing’s disease with reoperation and/or proton beam radiosurgery. Clin Neurosurg 55:141–144
Vance ML (2009) Cushing’s disease: radiation therapy. Pituitary 12(1):11. https://doi.org/10.1007/s11102-008-0117-3
Loeffler JS, Shih HA (2011) Radiation therapy in the management of pituitary adenomas. J Clin Endocrinol Metab 96(7):1992–2003. https://doi.org/10.1210/jc.2011-0251
Colin P, Jovenin N, Delemer B, Caron J, Grulet H, Hecart AC, Lukas C, Bazin A, Bernard MH, Scherpereel B, Peruzzi P, Nakib I, Redon C, Rousseaux P (2005) Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients. Int J Radiat Oncol Biol Phys 62(2):333–341. https://doi.org/10.1016/j.ijrobp.2004.09.058
Sheehan JP, Niranjan A, Sheehan JM, Jane JA Jr, Laws ER, Kondziolka D, Flickinger J, Landolt AM, Loeffler JS, Lunsford LD (2005) Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 102(4):678–691. https://doi.org/10.3171/jns.2005.102.4.0678
Fleseriu M, Petersenn S (2012) Medical management of Cushing’s disease: what is the future?. Pituitary 15(3):330–341. https://doi.org/10.1007/s11102-012-0397-5
Degerblad M, Rahn T, Bergstrand G, Thoren M (1986) Long-term results of stereotactic radiosurgery to the pituitary gland in Cushing’s disease. Acta Endocrinol 112(3):310–314
Devin JK, Allen GS, Cmelak AJ, Duggan DM, Blevins LS (2004) The efficacy of linear accelerator radiosurgery in the management of patients with Cushing’s disease. Stereotact Funct Neurosurg 82(5–6):254–262. https://doi.org/10.1159/000083476
Felix IA, Horvath E, Kovacs K (1981) Massive Crooke’s hyalinization in corticotroph cell adenomas of the human pituitary. A histological, immunocytological, and electron microscopic study of three cases. Acta Neurochir 58(3–4):235–243
Neumann PE, Horoupian DS, Goldman JE, Hess MA (1984) Cytoplasmic filaments of Crooke’s hyaline change belong to the cytokeratin class. An immunocytochemical and ultrastructural study. Am J Pathol 116(2):214–222
Horvath E, Kovacs K (1988) Fine structural cytology of the adenohypophysis in rat and man. J Electron Microsc Tech 8(4):401–432. https://doi.org/10.1002/jemt.1060080410
Flitsch J, Ludecke DK, Knappe UJ, Saeger W (1999) Correlates of long-term hypocortisolism after transsphenoidal microsurgery for Cushing’s disease. Exp Clin Endocrinol Diabetes 107(3):183–189. https://doi.org/10.1055/s-0029-1212095
Saeger W, Geisler F, Ludecke DK (1988) Pituitary pathology in Cushing’s disease. Pathol Res Pract 183(5):592–595. https://doi.org/10.1016/S0344-0338(88)80018-9
Castinetti F, Nagai M, Dufour H, Kuhn JM, Morange I, Jaquet P, Conte-Devolx B, Regis J, Brue T (2007) Gamma knife radiosurgery is a successful adjunctive treatment in Cushing’s disease. Eur J Endocrinol 156(1):91–98. https://doi.org/10.1530/eje.1.02323
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors certify that they do not have any conflict of interest.
Ethical approval
The study was approved by the Institutional Review Board (IRB) of University of Virginia (UVA).
Informed consent
This is a retrospective study and informed consent was not required.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Cordeiro, D., Xu, Z., Nasser, M. et al. The role of Crooke’s changes in recurrence and remission after gamma knife radiosurgery. J Neurooncol 142, 171–181 (2019). https://doi.org/10.1007/s11060-018-03078-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-018-03078-8